|
WO2017022650A1
|
|
MODIFIED siRNA, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
|
|
JP2013180992A
|
|
Il-8 suppressed expression medicine
|
|
EP2251436A1
|
|
Sirna detection method
|
|
JP2011032169A
|
|
4-aminopyrimidine derivative and medicinal composition containing the compound
|
|
WO2008047574A1
|
|
Sensitizer for anticancer agent
|
|
WO2007023782A1
|
|
Neutralizing antibody directed against killer toxin-like protein, and use thereof
|
|
WO2006129583A1
|
|
Pyrazolone derivative
|
|
EP1900728A1
|
|
Pharmaceutical composition comprising pyrazolone derivative
|
|
WO2006093071A1
|
|
ANTI-IDIOTYPE ANTIBODY HAVING ANTIFUNGAL ACTIVITY ON FUNGUS CARRYING β-GLUCAN SYNTHASE AND UTILIZATION OF THE SAME
|
|
JP2007161664A
|
|
Cancer cell-specific anticancer agent
|
|
KR20070088706A
|
|
Cancer-cell-specific cytostatic agent
|
|
KR20060135945A
|
|
Carcinoma cell-specific apoptosis-inducing agent targeting gene relevant to chromosome stabilization
|
|
JP2005312437A
|
|
Method for screening g2/m inhibitor and dna modifying agent and non-dna modifying agent using cell
|
|
EP1625853A1
|
|
Apoptosis inducer for cancer cell
|
|
JP2007000002A
|
|
Method for enhancing sensitivity to alkylating drug
|
|
JP2007131531A
|
|
IkappaBalpha UBIQUITINATION INHIBITOR
|
